<code id='BC1993B970'></code><style id='BC1993B970'></style>
    • <acronym id='BC1993B970'></acronym>
      <center id='BC1993B970'><center id='BC1993B970'><tfoot id='BC1993B970'></tfoot></center><abbr id='BC1993B970'><dir id='BC1993B970'><tfoot id='BC1993B970'></tfoot><noframes id='BC1993B970'>

    • <optgroup id='BC1993B970'><strike id='BC1993B970'><sup id='BC1993B970'></sup></strike><code id='BC1993B970'></code></optgroup>
        1. <b id='BC1993B970'><label id='BC1993B970'><select id='BC1993B970'><dt id='BC1993B970'><span id='BC1993B970'></span></dt></select></label></b><u id='BC1993B970'></u>
          <i id='BC1993B970'><strike id='BC1993B970'><tt id='BC1993B970'><pre id='BC1993B970'></pre></tt></strike></i>

          focus

          focus

          author:hotspot    Page View:9

          Has AI really solved biology? What can machines teach us about medicine? And what’s a digital twin?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. It’s our all-AI episode. First, STAT’s Casey Ross joins us to explain his reporting on how researchers and pharmaceutical firms are using the technology to find new drug targets, design therapies, and improve clinical trials. Then, we talk to Joel Dudley, a partner at the venture firm Innovation Endeavors, about how to discern promising ideas from wastes of time when it comes to AI in biotech.

          advertisement

          For more on what we cover, here’s the latest on AI in drug development; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          Wikipedia

          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more
          An inside look at PIPEs, biotech's buzzy new financing tool
          An inside look at PIPEs, biotech's buzzy new financing tool

          MollyFerguson/STATBiotechisawashinPIPEs.Thenumbersbehindtheseprivatelynegotiatedpurchasesofpublic-co

          read more
          George Santos makes 1st court appearance after pleading not guilty to 13 counts
          George Santos makes 1st court appearance after pleading not guilty to 13 counts

          1:57GeorgeSantosarrivesatfederalcourtJune30,2023,inCentralIslip,N.Y.JohnMinchillo/APRep.GeorgeSantos

          read more

          Kidney transplant patients stopped immunosuppressants in trial

          BRENDANSMIALOWSKI/AFP/GettyImagesKidneytransplantsarethemostcommonorgantransplantprocedureintheU.S.,